CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis
John J. Reynolds(University of Birmingham), Charles D. Pusey(Imperial College Healthcare NHS Trust), Jane Cross(Hammersmith Hospital), Anil Chandraker(Brigham and Women's Hospital), Ayman Karkar(MODUL University Dubai), Jennifer Smith(Hammersmith Hospital), Robert Peach(Bristol-Myers Squibb (United States)), Frederick W.K. Tam(Hammersmith Hospital), Mohamed H. Sayegh(American University of Beirut)
Cited by 176
Related Papers
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
|Immunity|1994|971
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|708
The promise of organ and tissue preservation to transform medicine
|Nature Biotechnology|2017|530
Role of the PD-1 Pathway in the Immune Response
|American Journal of Transplantation|2012|436